Gene encoding cellulase
View Patent ↗Polynucleotide sequences are provided encoding a thermostable cellulase and directing its increased expression are provided, and the use of the thermostable cellulase in hydraulic fracturing methods and the treatment of flowback fluids.
1. An isolated, recombinant, or synthetic nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:
(a) the nucleotide sequence of SEQ ID NO: 1; and
(b) a nucleotide sequence having at least 90% sequence identity to the nucleotide sequence of SEQ ID NO: 3 with at least five mutations selected from A54C, A57C, T66C, G81A, A84C, A6C, G6C, A9C, G9C, A15G, C15G, T22C, G22C, A24T, C24T, T33C, G33C, T39C, G39C, T40C, G40C, T42C, G42C, T54C, G54C, T57C, G57C, A66C, G66C, C81A, T81A, T84C, G84C, and any combination thereof,
wherein said nucleic acid molecule encodes a polypeptide having cellulase activity.
2. The isolated, recombinant, or synthetic nucleic acid molecule of claim 1 , wherein at least one of said mutations is silent.
3. The isolated, recombinant, or synthetic nucleic acid molecule of claim 1 , wherein at least one of said mutations directs expression of a cellulase from said sequence at a higher level than a reference nucleotide sequence lacking said at least one mutation.
4. The isolated, recombinant, or synthetic nucleic acid molecule of claim 1 , wherein said nucleotide sequence encodes the polypeptide set forth in the amino acid sequence of SEQ ID NO: 2 and, wherein said nucleotide sequence has been mutated with respect to a reference nucleotide sequence encoding the polypeptide set forth in the amino acid sequence of SEQ ID NO: 2 such that the expression level of said polypeptide by said mutated nucleotide sequence is increased relative to the expression level of said polypeptide encoded by said reference nucleotide sequence.
5. An isolated, recombinant, or synthetic nucleic acid molecule encoding a polypeptide comprising an amino acid sequence that has at least 90%, 95%, 97%, 98%, 99% or 100% sequence identity to the amino acid sequence of SEQ ID NO: 2 with at least five mutations corresponding to nucleotides at positions of the nucleotide sequence of SEQ ID NO: 1 selected from the group consisting of T6C, T9C, T15G, A22C, G24T, A33C, A39C, A40C, A42, A54C, A57C, T66C, G81A, A84C, A6C, G6C, A9C, G9C, A15G, C15G, T22C, G22C, A24T, C24T, T33C, G33C, T39C, G39C, T40C, G40C, T42C, G42C, T54C, G54C, T57C, G57C, A66C, G66C, C81A, T81A, T84C, G84C, and any combination thereof, wherein said nucleic acid molecule encodes a polypeptide having cellulase activity.
6. An isolated, recombinant, or synthetic nucleic acid molecule comprising a nucleotide sequence having at least 90% sequence identity to the nucleotide sequence of SEQ ID NO: 3 with at least two mutations selected from the group consisting of: T9C, T15G, A22C, G24T, A33C, A40C, A42C, A54C, A57C, T66C, G81A, A9C, G9C, A15G, C15G, T22C, G22C, A24T, C24T, T33C, G33C, T40C, G40C, T42C, G42C, T54C, G54C, T57C, G57C, A66C, G66C, C81A, T81A, and any combination thereof, wherein said nucleic acid molecule encodes a polypeptide having cellulase activity.
7. A bacterial expression system comprising the isolated, recombinant, or synthetic nucleic acid molecule of claim 1 , 5 , or 6 .
8. The bacterial expression system of claim 7 , wherein a cellulase encoded by said nucleic acid molecule is produced in said bacterial expression system at an amount that is at least 1.0 g/L, 2.0 g/L, 3.0 g/L, 4.0 g/L, 5.0 g/L, 6.0 g/L, 7.0 g/L, 8.0 g/L, 9.0 g/L, 10.0 g/L, 11.0 g/L, 12.0 g/L, 13.0 g/L, 14.0 g/L, 15.0 g/L, 16.0 g/L, 17.0 g/L, 18.0 g/L, 19.0 g/L, 20.0 g/L, 21.0 g/L, 22.0 g/L, 23.0 g/L, 24.0 g/L, 25.0, g/L, 26.0 g/L, 27.0 g/L, 28.0 g/L, 29.0 g/L, 30.0 g/L, 31.0 g/L, 32.0 g/L, 33.0 g/L, 34.0 g/L, or 35.0 g/L.
9. The bacterial expression system of claim 7 , wherein said bacterial expression system is a gram-negative bacterial expression system.
10. The gram-negative bacterial expression system of claim 9 , wherein said gram-negative bacterial expression system is a Pseudomonas, E. coli, Ralstonia , or Caulobacter expression system.
11. The gram-negative bacterial expression system of claim 10 , wherein said gram-negative bacterial expression system is a recombinant Pseudomonas fluorescens expression system.
12. The isolated, recombinant, or synthetic nucleic acid molecule of claim 6 , wherein at least one of said mutations is silent.
13. The isolated, recombinant, or synthetic nucleic acid molecule of claim 6 , wherein at least one of said mutations directs expression of a cellulase from said sequence at a higher level than a reference nucleotide sequence lacking said at least one mutation.
14. The isolated, recombinant, or synthetic nucleic acid molecule of claim 6 , wherein said nucleotide sequence encodes the polypeptide set forth in the amino acid sequence of SEQ ID NO: 2 and, wherein said nucleotide sequence has been mutated with respect to a reference nucleotide sequence encoding the polypeptide set forth in the amino acid sequence of SEQ ID NO: 2 such that the expression level of said polypeptide by said mutated nucleotide sequence is increased relative to the expression level of said polypeptide encoded by said reference nucleotide sequence.